Wong Justin H, Na Yujin, Parsa Fereydoun D
Department of Medicine, University of Hawaii John A. Burns School of Medicine, Honolulu, USA.
Department of Surgery, Division of Plastic Surgery, University of Hawaii John A. Burns School of Medicine, Honolulu, USA.
Cureus. 2024 Dec 30;16(12):e76605. doi: 10.7759/cureus.76605. eCollection 2024 Dec.
Opioid medications are commonly employed for perioperative and postoperative pain management. However, these medications can negatively impact the body's innate pain management system, specifically the action of beta-endorphins. By impairing the function of mu-opioid receptors and inhibiting the release of beta-endorphin, opioids may exacerbate and prolong postoperative pain. Additionally, opioid use is associated with numerous side effects, including nausea, vomiting, constipation, excessive sedation, clouded sensorium, dizziness, respiratory depression, and addiction, all of which may impede postoperative patient recovery and outcome quality. The purpose of this article is to explore the intricate relationship between opioid medications and endogenous beta-endorphins, examine nonopioid modalities for postoperative pain control, and elucidate the applications of non-narcotic perioperative enhanced recovery after surgery protocols in improving patient outcomes.
阿片类药物常用于围手术期和术后疼痛管理。然而,这些药物会对身体的固有疼痛管理系统产生负面影响,特别是β-内啡肽的作用。通过损害μ-阿片受体的功能并抑制β-内啡肽的释放,阿片类药物可能会加剧并延长术后疼痛。此外,使用阿片类药物会带来许多副作用,包括恶心、呕吐、便秘、过度镇静、意识模糊、头晕、呼吸抑制和成瘾,所有这些都可能妨碍术后患者的恢复和预后质量。本文的目的是探讨阿片类药物与内源性β-内啡肽之间的复杂关系,研究术后疼痛控制的非阿片类方法,并阐明非麻醉性围手术期术后加速康复方案在改善患者预后方面的应用。